Volitionrx (VNRX) Net Income towards Common Stockholders (2019 - 2025)
Historic Net Income towards Common Stockholders for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to -$31433.0.
- Volitionrx's Net Income towards Common Stockholders rose 9946.01% to -$31433.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.3 million, marking a year-over-year increase of 6211.8%. This contributed to the annual value of -$27.0 million for FY2024, which is 2364.51% up from last year.
- According to the latest figures from Q3 2025, Volitionrx's Net Income towards Common Stockholders is -$31433.0, which was up 9946.01% from $29992.0 recorded in Q2 2025.
- Over the past 5 years, Volitionrx's Net Income towards Common Stockholders peaked at $94092.0 during Q4 2022, and registered a low of -$9.5 million during Q2 2023.
- In the last 5 years, Volitionrx's Net Income towards Common Stockholders had a median value of -$31433.0 in 2025 and averaged -$3.5 million.
- Per our database at Business Quant, Volitionrx's Net Income towards Common Stockholders surged by 79109.72% in 2022 and then plummeted by 1217748.5% in 2023.
- Volitionrx's Net Income towards Common Stockholders (Quarter) stood at $73088.0 in 2021, then increased by 28.74% to $94092.0 in 2022, then plummeted by 9344.41% to -$8.7 million in 2023, then skyrocketed by 33.4% to -$5.8 million in 2024, then surged by 99.46% to -$31433.0 in 2025.
- Its Net Income towards Common Stockholders was -$31433.0 in Q3 2025, compared to $29992.0 in Q2 2025 and -$5.5 million in Q1 2025.